Edgewise Therapeutics Inc.
EWTX | NASDAQ
$45.80
+$1.16 (+2.60%)
Sep 22, 2026, 11:54 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -15.23 | -18.41 | -6.97 | -7.10 | -17.77 | -85.71 |
PEG Ratio | -1.23 | 2.41 | -0.28 | -0.15 | -0.12 | -1.02 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 4.89 | 5.37 | 2.19 | 1.38 | 2.76 | -44.18 |
P/FCF Ratio | -17.76 | -22.36 | -7.14 | -8.24 | -22.13 | -99.52 |
P/OCF Ratio | -17.76 | -22.63 | -7.58 | -9.10 | -22.57 | -100.90 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | n/a | -4.79 |
Quick Ratio | 19.85 | 19.93 | 19.50 | 21.53 | 26.97 | 29.86 |
Current Ratio | 19.85 | 19.93 | 19.50 | 21.53 | 26.97 | 29.86 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | -17.83 | n/a | n/a |
Return on Equity | -32.13% | -29.14% | -31.42% | -19.51% | -15.60% | 51.03% |
Return on Assets | -30.36% | -27.49% | -29.46% | -18.43% | -15.01% | -13% |
Return on Invested Capital | -36.37% | -34.23% | -35.27% | -20.41% | -15.73% | -13.56% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove EWTX